webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate

  CAS No.: 1042435-35-7   Cat No.: BADC-00514   Purity: 95% 4.5  

2-(2-(2-(3-((2, 5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropoxy)ethoxy)ethoxy)ethyl acrylate is a PEG linker for antibody-drug-conjugation (ADC).

2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate

Structure of 1042435-35-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H23NO9
Molecular Weight
373.36
Shipping
Room temperature, or blue ice upon request.
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]propanoate
Canonical SMILES
C=CC(=O)OCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O
InChI
InChI=1S/C16H23NO9/c1-2-15(20)25-12-11-24-10-9-23-8-7-22-6-5-16(21)26-17-13(18)3-4-14(17)19/h2H,1,3-12H2
InChIKey
VTVFTDSRFVBRQJ-UHFFFAOYSA-N
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C

Biomedical Research: Dive into the cutting-edge realm of biocompatible hydrogel development in tissue engineering and regenerative medicine, where the extraordinary 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate takes center stage. Researchers co-polymerize this compound with other monomers, crafting materials that not only support cell attachment, proliferation, and differentiation but also mimic the intricate nuances of the extracellular matrix. These versatile hydrogels open doors to advanced wound dressings and organ repair scaffolds that boast unparalleled functionality and adaptability, ushering in a new era of medical material innovation.

Drug Delivery Systems: Venture into the world of controlled drug delivery systems, where scientists harness the potential of 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate to revolutionize pharmaceutical delivery. By incorporating this compound into nanoparticle or micelle structures, drugs are encapsulated and released with precise control, amplifying therapeutic efficacy while minimizing unwanted side effects. This seamless interplay reshapes the future of drug delivery, ushering in a new era of targeted precision medicine.

Surface Modification: Witness the pivotal role played by 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate in enhancing the biocompatibility of medical devices and combatting biofouling. Through grafting this acrylate onto implants or catheters, a hydrophilic and protein-resistant layer is crafted, mitigating immune reactions and bacterial colonization. This customized enhancement not only prolongs device lifespan but also significantly boosts functionality, setting unprecedented benchmarks for performance and reliability in biomedical devices.

Polymer Science: Immerse yourself in the forefront of polymer synthesis, where the versatile 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate shines as a key reactive monomer. This compound plays a pivotal role in creating functional polymers with tailored properties like flexibility, hydrophilicity, and biodegradability, catering to diverse applications spanning from contact lenses to biodegradable plastics and responsive materials. Its unique chemical structure seamlessly integrates into polymer networks, offering bespoke performance characteristics that drive innovation and versatility across a spectrum of industrial applications, shaping the future of polymer science with boundless possibilities.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Propargyl-PEG7-acid | 2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate | 3-azidopropanoate-N-hydroxysuccinimide ester | NHPI-PEG3-C2-PFP ester | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate | Fmoc-Gly-Gly-Phe-OtBu | NHPI-PEG3-C2-NHS ester | 2,5-dioxopyrrolidin-1-yl 3-Iodo-4-methoxybenzoate | NHPI-PEG2-C2-NHS ester | NHPI-PEG4-C2-PFP ester | 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate
Send Inquiry
Verification code
Inquiry Basket